🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

12+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 12 of 12 recruiting trials for “primary-erythromelalgia”

NARecruitingNCT07362225 ↗

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

👨‍⚕️ Raajit Rampal, MD, PhD, Memorial Sloan Kettering Cancer Center📍 2 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07232290 ↗

Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera

👨‍⚕️ Lei Zhang, Doctor, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06985147 ↗

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

👨‍⚕️ Will Savage, MD PhD, Disc Medicine📍 14 sites📅 Started Aug 2025View details ↗
RecruitingNCT06743035 ↗

Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

👨‍⚕️ Eyck von der Heyde, Dr., Onkologische Schwerpunktpraxis📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06752941 ↗

LOW-PV Continuation

👨‍⚕️ TIZIANO BARBUI, MD, FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS📍 13 sites📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06093672 ↗

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

🏥 Italfarmaco📍 90 sites📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06752746 ↗

A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera

🏥 Mabwell (Shanghai) Bioscience Co., Ltd.📍 6 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT05870475 ↗

Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV

👨‍⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jun 2023View details ↗
RecruitingNCT05396170 ↗

Effect of Phlebotomy on Heartrate in Polycythemia Patients

👨‍⚕️ Jaap Jan Zwaginga, MD, PhD, LUMC📍 1 site📅 Started Jul 2022View details ↗
Phase 3RecruitingNCT04655092 ↗

Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

👨‍⚕️ Keita Kirito, MD, University of Yamanashi Hospital📍 6 sites📅 Started Jan 2021View details ↗
Phase 3RecruitingNCT04116502 ↗

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

👨‍⚕️ Claire Harrison, Acting on behalf of the Sponsor (UK), Guy's Hospital, London, UK, SE1 9RT📍 47 sites📅 Started Oct 2019View details ↗
NARecruitingNCT04039633 ↗

Spinal Cord Stimulation for Refractory Pain in Erythromelalgia

👨‍⚕️ Sasha Gulati, md prof, St. Olavs Hospital📍 4 sites📅 Started Aug 2019View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →